Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Revance Therapeutics (RVNC)

  • Company Report
  • Nov. 08, 2022, 15:48 UTC
  • 86
  • 0 comments

New Form 10-Q for Revance Therapeutics, Inc.

Comment Full text

Albireo Pharma Inc. (ALBO)

  • Company Report
  • Nov. 08, 2022, 15:48 UTC
  • 87
  • 0 comments

New Form 10-Q for Albireo Pharma Inc

Comment Full text

Corbus Pharmaceuticals Holdings Inc. (CRBP)

  • Company Report
  • Nov. 08, 2022, 15:48 UTC
  • 84
  • 0 comments

New SEC Form for Corbus Pharmaceuticals Holdings, Inc.

Comment Full text

Sutro Biopharma Inc (STRO)

  • Company Report
  • Nov. 08, 2022, 15:48 UTC
  • 82
  • 0 comments

New SEC Form for Sutro Biopharma, Inc.

Comment Full text

Assembly Biosciences Inc. (ASMB)

  • Company Report
  • Nov. 08, 2022, 15:29 UTC
  • 82
  • 0 comments

New Form 10-Q for Assembly Biosciences, Inc.

Comment Full text

Pacific Biosciences of California Inc (PACB)

  • Company Report
  • Nov. 08, 2022, 15:29 UTC
  • 84
  • 0 comments

New Form 10-Q for Pacific Biosciences of California Inc

Comment Full text

Axogen Inc. (AXGN)

  • Company Report
  • Nov. 08, 2022, 15:29 UTC
  • 91
  • 0 comments

New SEC Form for Axogen, Inc.

Comment Full text

Processa Pharmaceuticals Inc. (PCSA)

  • Company Report
  • Nov. 08, 2022, 15:29 UTC
  • 86
  • 0 comments

New SEC Form for Processa Pharmaceuticals, Inc.

Comment Full text

Ligand Pharmaceuticals Incorporated (LGND)

  • Company Report
  • Nov. 08, 2022, 15:29 UTC
  • 104
  • 0 comments

New SEC Form for Ligand Pharmaceuticals Incorporated

Comment Full text

Electromed Inc. (ELMD)

  • Company Report
  • Nov. 08, 2022, 15:28 UTC
  • 90
  • 0 comments

SmartVest - First Quarter 2023

Comment Full text
  • Previous
  • 46
  • 47
  • 48
  • 49
  • 50
  • Next

Search

News categories

  • Technical Exchange News(10587)
  • Event(1974)
  • SEC News(184241)
  • FDA Approval(9830)
  • Company Report(721)
  • Business News(122111)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin